Clinical Genitourinary Cancer Template
Write in a clean editor, then format for Clinical Genitourinary Cancer in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Clinical Genitourinary Cancer format
Clinical Genitourinary Cancer is a peer-reviewed journal published by Elsevier, covering Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment, Prostate Cancer Treatment and Research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Genitourinary Cancer 12 (2023) 45–58.
Formats any DOI in Clinical Genitourinary Cancer style. No sign-up. |
| Publishes research in | Bladder and Urothelial Cancer Treatments Renal cell carcinoma treatment Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Urinary and Genital Oncology Studies |
| ISSN | 1558-7673 |
| Citation impact (2-yr) | 2.35 |
| h-index | 68 |
| i10-index | 1,328 |
| Total citations | 42,225 |
| Article processing charge | $3,580 |
| Top institutions publishing here | Dana-Farber Cancer Institute |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Clinical Genitourinary Cancer per year
Citation impact of Clinical Genitourinary Cancer by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Clinical Genitourinary Cancer
BACKGROUND: Clinical trials have demonstrated the efficacy of several life-prolonging therapies for metastatic castration-resistant prostate cancer (mCRPC); however, real-world data on their use, survival effect, and safety are limited. Using electronic health record data from the Flatiron Health database, we studied real-world treatment patterns and health outcomes in patients with mCRPC. PATIENTS AND METHODS: We…